Copper-Mediated Catalysis? The discovery of missense mutations in the gene cod-SOD1 is an abundant and ubiquituously expressed proing for the Cu/Zn superoxide dismutase 1 (SOD1) eight tein. In view of its normal function in catalyzing the conyears ago in subsets of familial cases provided much version of superoxide anions to hydrogen peroxide (Fighope for quick development of therapies, and it directed ure 1), it was initially thought that the toxicity of different most ALS research on elucidating the mechanism of SOD1 mutants could result from decreased free-radical SOD1-mediated disease. Yet, understanding the toxicity scavenging activity. However, this idea was not supof SOD1 mutants has been surprisingly challenging. Imported by measurement of enzymatic activities and by portant efforts have also been devoted to clarifying the transgenic mouse studies. Different SOD1 mutations role of neurofilaments in ALS pathogenesis. Again, studshow a remarkable degree of variation with respect to ies with transgenic mice yielded complex results. Here, enzymatic activity, polypeptide half-life, and resistance I shall review the current hypotheses on mechanisms of to proteolysis, and these variables did not correlate ALS disease with emphasis on toxicity of SOD1 mutants with age of onset or rapidity of human disease progresand on cytoskeletal abnormalities.
ated catalysis as potential sources of toxicity. One proment can be applied for the peroxidase activity hypothesis. Yet, neither the elimination of endogenous SOD1 posal is that misfolding of SOD1 induced by mutations would allow the access of abnormal substrates such as nor addition of wild-type SOD1 affected disease progression in SOD1 G85R mice. Thus, these results are inconperoxynitrite to the catalytic site leading to the nitration of tyrosine residues (Beckman et al. wild-type SOD1 and mutant SOD1 lacking zinc were equally toxic to cultured neurons. However, the in vivo However, the peroxynitrite or peroxidase activity hypotheses have been challenged by results of experirelevance of this hypothesis has been questioned due to results from transgenic mice (Williamson et al., 2000 G85R mutants would be predicted to increase superoxide levels and its prodtheless, the possibility exists that inducible NOS (iNOS) is being used as an alternative source for nitric oxide uct peroxynitrite while the elevation of normal SOD1 activity would do the opposite (Figure 1) . A similar argusince immunoreactivity for iNOS has been detected in 
, 2000). tional protein modifications. Of particular relevance to ALS is the recent finding that excitotoxicity can induce The presence of abnormal neurofilament inclusions in familial ALS caused by SOD1 mutations and in mice neurofilament side-arm hyperphosphorylation in neurons and a slowing of neurofilament transport in cultured expressing mutant SOD1 supported the possibility that neurofilaments may act as toxic intermediates in the neurons (Ackerley et al., 2000). This phosphorylation may occur via members of the MAPK family including disease. To test this idea, mice expressing mutant SOD1 in NF-L knockout background (Williamson et al., 1998) p42/p44MAPK and SAPKs. Other posttranslational protein modifications may also be involved in disorganizaor in a transgenic NF-H-␤-galactosidase background (Eyer et al., 1998) were generated. NF-H-␤-galactosition of neurofilaments. The presence of advanced glycation end products in neurofilament inclusions is
dase is a fusion protein that leads to the trapping of neurofilaments in neuronal perikarya. Because motor associated with ALS. In addition, the NF-L protein is very susceptible to peroxynitrite-mediated nitration. neuron disease still occurred in both of these mutant SOD1 mice strains lacking axonal neurofilaments, one However, although neurofilament inclusions in ALS are stained with anti-nitrotyrosine antibodies, the extent of might conclude that axonal neurofilaments are not required for mutant SOD1-mediated disease (see Table  nitration of tyrosine residues in the NF-L protein from the spinal cord of sporadic ALS cases did not differ from 2). However, the absence of NF-L did lead to ‫%51ف‬ extension of life span in SOD1 G85R mice. Even more surage-matched controls (Strong et al., 1998).
For some time, the neurofilament accumulations in prising was the observation that the overexpression of wild-type human NF-H or to a lower extent mouse NF-H ALS were widely viewed as a marker of neuronal dysfunction, perhaps reflecting axonal transport defects.
proteins, which raises perikaryal neurofilament content and lowers axonal levels, extended the longevity of muHowever, recent transgenic mouse studies suggested that neurofilament accumulations could play a pathotant SOD1 mice by 65% and 15%, respectively et al., 2000) . Such modulation of gene expression in mice. As mentioned above, the highest documented effect on longevity of peripherin inclusions, as described above for neurofila- Nonetheless, in light of current knowledge of disease pathways contribute to mechanisms of motor neuron mechanism, antiapoptotic drugs such as caspase inhibideath in ALS merits further investigation even though tors and perhaps anti-inflammatory agents could offer an immune mechanism could represent a response secpotential treatment. Other strategies might include a ondary to neurodegeneration rather than a primary search for agents that can prevent the abnormal aggrecause of disease. gation of mutant SOD1 or the formation of peripherin/ neurofilament inclusion bodies. As more associated Future Directions genes are discovered, new therapeutic approaches Evidence to date suggests that the pathway to motor could potentially be derived. Gene therapy approaches neuron death in ALS is complex and involves multiple involving the use of recombinant viruses offer a promiscascades of events including formation of protein aggreing strategy for the delivery of genes to enhance motor gates, oxidative damage, mitochondrial defects, alterneuron survival and repair. The next few years will also ations in calcium homeostasis, caspase activation, and provide some perspective on whether neural stem cells changes in levels of Bcl-2 (Figure 3) . Intracytoplasmic with the potential to differentiate into appropriate cells aggregates, formed by mutant SOD1 or IF proteins, can be used to replace motor neurons or to repair damemerged as important factors of toxicity that may interaged neurons via delivery of growth factors. In view of fere perhaps with intracellular transport and proteosome the complexity of the disease, a combination of different ubiquitin functions. Protein aggregates and damage octherapies acting in synergy will probably be needed for cur in both neurons and astrocytes, but the degree to effective ALS treatment. which gliosis contributes to motor neuron disease is not New technologies will likely drive future progress. For established. Excitotoxicity due to astrocyte dysfunction instance, the use of cDNA microarray technologies can and inflammatory processes from microglia activation be applied to compare the gene expression profile from are additional factors that may contribute to the spreadsporadic and familial ALS cases, including cases linked ing of the neurodegenerative process.
to SOD1 mutations. This will help to determine to what The current knowledge of pathogenic mechanisms of extent the two forms of the disease share similar degen-ALS is mostly based on studies with mutant SOD1, erative processes, a crucial issue for clinical intervenwhich is responsible for only ‫%2ف‬ of all ALS cases. For tion. Other questions related to SOD1-mediated disease the vast majority of ALS patients, the primary causes of need to be explored. It is not fully resolved how misdisease are unknown. Thus, there is a need to identify folded SOD1 mutants can trigger by aggregation death new genes associated with familial forms of ALS. Anpathways selectively in subsets of motor neurons. The other promising approach will be to identify genes molecular mechanisms in various cell types that contribwhose mutation in mice produce ALS-like conditions. ute to the onset and rapid spreading of motor neuron Mutagenesis in mice using the chemical mutagen ethyldeath are not completely understood. In this regard, nitrosourea is now being used for large-scale screening profiling the differential gene expression in various tisof genes and pathways involved in various phenotypes.
sues during disease progression in existing mouse models of ALS should provide a better understanding of the In addition, the existing mouse models of ALS provide 
